ScreenerHero

NIKINiki BioSolutions Inc. Common Stock

NAS · US · Healthcare · Biotechnology · aptorumgroup.com
8.580USDMkt Cap: 6.99M $P/E: —

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and inf…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap6.99M $
Enterprise Value-2.70M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-1.36M $
Revenue/Share—
Last Price8.580 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA1.73
EV/Revenue—
P/S—
P/B0.29
EPS (TTM)-1.90
EPS (Forward)—
52W Range
7.75066% of range9.010
52W High9.010 USD
52W Low7.750 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-5.89%
ROA-7.29%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.84M $
CapEx (TTM)—
FCF Margin—
FCF Yield-15.71%
Net Debt-9.96K $
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity0.15
Current Ratio0.78
Quick Ratio0.75
Book Value/Sh28.38 USD
Cash/Share4.240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.634.68K
Float535.93K
Insiders47.41%
Institutions0.28%
Short Interest
Short Ratio0.1d
Short % Float4.24%
Short % Out.3.04%
Shares Short24.79K
Short (prev mo.)10.16K
Technical
SMA 508.539 (+0.5%)
SMA 2009.741 (-11.9%)
Beta0.18
S&P 52W Chg21.00%
Avg Vol (30d)30.41K
Avg Vol (10d)25.42K
Technical Indicators
RSI (14)49.1
MACD-0.0866
MACD Signal0.0257
MACD Hist.-0.1123
BB Upper10.19 USD
BB Middle8.931 USD
BB Lower7.674 USD
BB Width28.16%
ATR (14)0.9511 USD
Vol Ratio (20d)1.08x